Combination therapy of menstrual derived mesenchymal stem cells and antibiotics ameliorates survival in sepsis

INTRODUCTION: Sepsis is a clinical syndrome associated with a severe systemic inflammation induced by infection. Although different anti-microbial drugs have been used as treatments, morbidity and mortality rates remain high. Mesenchymal stem cells (MSCs) derived from the bone marrow have demonstrat...

Descripción completa

Detalles Bibliográficos
Autores principales: Alcayaga-Miranda, Francisca, Cuenca, Jimena, Martin, Aldo, Contreras, Luis, Figueroa, Fernando E., Khoury, Maroun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4609164/
https://www.ncbi.nlm.nih.gov/pubmed/26474552
http://dx.doi.org/10.1186/s13287-015-0192-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4609164/
https://www.ncbi.nlm.nih.gov/pubmed/26474552
http://dx.doi.org/10.1186/s13287-015-0192-0

Ejemplares similares